Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

QVC Group, Inc. Director's Dealing 2021

Dec 8, 2021

34089_dirs_2021-12-08_266e282a-282c-4064-8211-91fdddb9f552.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Qurate Retail, Inc. (QRTEA)
CIK: 0001355096
Period of Report: 2021-12-06

Reporting Person: Gilchrist Malcolm Ian Grant (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-06 Restricted Stock Units - QRTEA $ A 14188.0000 Acquired 2022-12-06 Series A Common Stock (14188.0000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) - QRTEA $4.2100 2026-12-09 Series A Common Stock (82297.0000) 82297.0000 Direct
Stock Option (right to buy) - QRTEA $10.8000 2025-12-06 Series A Common Stock (32460.0000) 32460.0000 Direct
Stock Option (right to buy) - QRTEA $11.8500 2024-12-12 Series A Common Stock (21597.0000) 21597.0000 Direct
Stock Option (right to buy) - QRTEA $12.8200 2022-12-17 Series A Common Stock (9617.0000) 9617.0000 Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

F2: On November 4, 2021, the Issuer announced that its board of directors declared a special cash dividend in the amount of $1.25 per common share payable on November 22, 2021, to all holders of record of the Issuer's common stock at the close of business on November 15, 2021 (the "Dividend"). This stock option award was previously reported as an option relating to 70,209 shares of the Issuer's Series A common stock at an exercise price of $4.92 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended ("Rule 16b-3").

F3: The derivative security is fully vested.

F4: This stock option award was previously reported as an option relating to 27,746 shares of the Issuer's Series A common stock at an exercise price of $12.64 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.

F5: This stock option award was previously reported as an option relating to 18,453 shares of the Issuer's Series A common stock at an exercise price of $13.87 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.

F6: This stock option award was previously reported as an option relating to 8,226 shares of the Issuer's Series A common stock at an exercise price of $15.00 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.